These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 67948)

  • 1. Kinetics of 3H-testosterone and 3H-dihydrotestosterone metabolism in patients with benign prostatic hypertrophy. Effect of cyproterone acetate.
    Hutschenreiter G; Sinterhauf K; Altwein JE
    Eur Urol; 1977; 3(2):100-4. PubMed ID: 67948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone metabolism in benign prostatic hypertrophy: in vivo studies of gestonorone caproate and cyproterone acetate.
    Orestano F; Altwein JE
    Br J Urol; 1976 Dec; 48(6):485-91. PubMed ID: 64267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and mode of action of androgens in target tissues of male rats. V. Uptake and metabolism of cyproterone acetate and its influence on the uptake and metabolism of testosterone and 5alpha-dihydrotestosterone in target organs and peripheral tissues.
    Szalay R; Krieg M; Schmidt H; Voigt KD
    Acta Endocrinol (Copenh); 1975 Nov; 80(3):592-602. PubMed ID: 1242572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer.
    Rost A; Schmidt-Gollwitzer M; Hantelmann W; Brosig W
    Prostate; 1981; 2(3):315-22. PubMed ID: 6458025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.
    Geller J; Albert J; Geller S; Lopez D; Cantor T; Yen S
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1000-8. PubMed ID: 62759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
    Bartsch G; Oberholzer M; Rohr HP
    Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offenders.
    Jeffcoate WJ; Matthews RW; Edwards CR; Field LH; Besser GM
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):189-95. PubMed ID: 6777092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men.
    Føgh M; Corker CS; Hunter WM; McLean H; Philip J; Schou G; Skakkebaek NE
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):545-52. PubMed ID: 474042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol-17 beta inhibition of androgen uptake, metabolism and binding in epididymis of adult male rats in vivo: a comparison with cyproterone acetate.
    Tindall DJ; French FS; Nayfeh SN
    Steroids; 1981 Mar; 37(3):257-68. PubMed ID: 6453438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyproterone acetate on the plasma gonadotrophin response to gonadotrophin releasing hormone.
    Donald RA; Espiner EA; Cowles RJ; Fazackerley JE
    Acta Endocrinol (Copenh); 1976 Apr; 81(4):680-4. PubMed ID: 769466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine effects of cyproterone acetate in patients with prostatic cancer.
    Isurugi K; Fukutani K; Ishida H; Hosoi Y
    J Urol; 1980 Feb; 123(2):180-3. PubMed ID: 7354512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
    Zgliczynski S; Baranowska B; Szymanowski J
    J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the role of the sex-hormone-binding globulin (SHBG) in prostatic gland hypertrophy in men. II. In vitro research.
    Pachman A
    Int Urol Nephrol; 1984; 16(3):211-7. PubMed ID: 6207132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
    de Jong FH; Reuvers PJ; Bolt-de Vries J; Mulder E; Blom JH; Schroeder FH
    J Steroid Biochem Mol Biol; 1992 Mar; 42(1):49-55. PubMed ID: 1373073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
    Cochran RC; Ewing LL; Niswender GD
    Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
    Suraci C; Costa C; De Pedrini P
    Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men.
    Knuth UA; Hano R; Nieschlag E
    J Clin Endocrinol Metab; 1984 Nov; 59(5):963-9. PubMed ID: 6237116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies on the antiandrogenic effects of cimetidine versus cyproterone acetate in rats.
    Baba S; Paul HJ; Pollow K; Janetschek G; Jacobi GH
    Prostate; 1981; 2(2):163-74. PubMed ID: 6458024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.
    Varenhorst E; Wallentin L; Carlström K
    Scand J Urol Nephrol; 1982; 16(1):31-6. PubMed ID: 6211762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
    Katayama T; Umeda K; Kazama T
    Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.